UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Leukemia, 2014-07, Vol.28 (7), p.1529-1536

2014

Volltextzugriff (PDF)

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma

Leukemia, 2012-07, Vol.26 (7), p.1675-1680

2012

Volltextzugriff (PDF)

Abstract No. 26: Rotary-powered bone marrow access results in shorter procedure time, larger core specimens and less residual pain for patients

Journal of vascular and interventional radiology, 2011, Vol.22 (3), p.S15-S15

2011

Volltextzugriff (PDF)

Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists

Journal of medicinal chemistry, 1996-12, Vol.39 (25), p.4867-4870

1996

Volltextzugriff (PDF)

A phase II study of pegylated liposomal doxorubicin, bortezomib, dexamethasone, and lenalidomide (DVD-R) for patients with relapsed/refractory (R/R) multiple myeloma (MM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8082-8082

2011

Volltextzugriff (PDF)

A phase I/II study of oral melphalan (MEL) combined with panobinostat (PAN) for patients with relapsed or refractory (R/R) multiple myeloma (MM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18574-e18574

2011

Volltextzugriff (PDF)

A retrospective review of pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone (DVD) for relapsed or refractory (R/R) multiple myeloma (MM)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e19523-e19523

2009

Volltextzugriff (PDF)

Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation

Journal of medicinal chemistry, 1994-03, Vol.37 (6), p.769-780

1994

Volltextzugriff (PDF)

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

American journal of hematology, 2011-01, Vol.86 (1), p.25-30

2011

Volltextzugriff (PDF)

Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8070-8070

2011

Volltextzugriff (PDF)

A phase II study of a modified pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone regimen for patients with previously untreated multiple myeloma (MM)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8134-8134

2010

Volltextzugriff (PDF)

A phase II study of a 1-hour infusion of romidepsin combined with bortezomib for multiple myeloma (MM) patients with relapsed or refractory disease

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e19508-e19508

2009

Volltextzugriff (PDF)

Percutaneous Tube Drainage: The Treatment of Choice for Refractory Lung Abscess

The Annals of thoracic surgery, 1985-03, Vol.39 (3), p.266-270

1985

Volltextzugriff (PDF)

Marked improvement in bone mineral density (BMD) for patients (pts) with monoclonal gammopathy of undetermined significance (MGUS) using zoledronic acid (ZOL)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8550-8550

2008

Volltextzugriff (PDF)

Factors that determine survival among patients with multiple myeloma (MM) treated with zoledronic acid (ZOL)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e19519-e19519

2009

Volltextzugriff (PDF)

L‐Asparaginase: A Review

Advances in Enzymology and Related Areas of Molecular Biology, 1973, p.185-248

1973

Volltextzugriff (PDF)

A Retrospective Study to Evaluate the Work-up and Follow-up of Patients With Monoclonal Gammopathy of Undetermined Significance

Clinical lymphoma, myeloma and leukemia, 2011-08, Vol.11 (4), p.336-341

2011

Volltextzugriff (PDF)

The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists

Advanced drug delivery reviews, 1997-01, Vol.23 (1), p.133-142

1997

Volltextzugriff (PDF)

Relationship between anti-diarrheal activity and binding to calmodulin

European journal of pharmacology, 1982-03, Vol.78 (3), p.375-377

1982

Volltextzugriff (PDF)

Histamine receptors in the myenteric plexus-longitudinal muscle of the guinea-pig ileum: H1- and H2-receptor-mediated potentiation of the contractile response to electrical stimulation

The Journal of pharmacology and experimental therapeutics, 1982-10, Vol.223 (1), p.177

1982

Volltextzugriff (PDF)

A Facile and Versatile Synthesis of 2-Substituted Tryptophans as Nα-tert- Butyloxycarbonyl Derivatives

Synthesis (Stuttgart), 1988, Vol.1988 (1), p.73-76

1988

Volltextzugriff (PDF)

Regulation by monovalent cations of histamine H2 receptor-coupled adenylate cyclase from guinea pig fundic gastric mucosa

Life sciences (1973), 1983-08, Vol.33 (9), p.895-902

1983

Volltextzugriff (PDF)

Imidazole derivatives—A new class of microsomal enzyme inhibitors

Biochemical pharmacology, 1972-12, Vol.21 (23), p.3187-3192

1972

Volltextzugriff (PDF)

Estradiol 17β-hemisuccinate: an improved procedure

Journal of lipid research, 1972-07, Vol.13 (4), p.554-555

Yellin, Tobias O.

1972

Volltextzugriff (PDF)

Differences in the interaction of histamine H2 receptor antagonists and tricyclic antidepressants with adenylate cyclase from guinea pig gastric mucosa

Biochemical pharmacology, 1984-11, Vol.33 (22), p.3621-3625

1984

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Physical Sciences
(81)
Physics
(79)
Life Sciences & Biomedicine
(41)
Physics, Particles & Fields
(37)
Physics Of Elementary Particles And Fields
(31)
Animals
(28)
Astronomy & Astrophysics
(25)
Male
(23)
Physics, Multidisciplinary
(22)
Biological And Medical Sciences
(21)
Humans
(19)
Elementary Particles
(18)
Cross Sections
(16)
Female
(16)
Interactions
(16)
Particle Interactions
(16)
Hadrons
(15)
Medical Sciences
(15)
Physics, Nuclear
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma

Abstract No. 26: Rotary-powered bone marrow access results in shorter procedure time, larger core specimens and less residual pain for patients

Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists

A phase II study of pegylated liposomal doxorubicin, bortezomib, dexamethasone, and lenalidomide (DVD-R) for patients with relapsed/refractory (R/R) multiple myeloma (MM)

A phase I/II study of oral melphalan (MEL) combined with panobinostat (PAN) for patients with relapsed or refractory (R/R) multiple myeloma (MM)

A retrospective review of pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone (DVD) for relapsed or refractory (R/R) multiple myeloma (MM)

Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial

A phase II study of a modified pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone regimen for patients with previously untreated multiple myeloma (MM)

A phase II study of a 1-hour infusion of romidepsin combined with bortezomib for multiple myeloma (MM) patients with relapsed or refractory disease

Percutaneous Tube Drainage: The Treatment of Choice for Refractory Lung Abscess

Marked improvement in bone mineral density (BMD) for patients (pts) with monoclonal gammopathy of undetermined significance (MGUS) using zoledronic acid (ZOL)

Factors that determine survival among patients with multiple myeloma (MM) treated with zoledronic acid (ZOL)

L‐Asparaginase: A Review

A Retrospective Study to Evaluate the Work-up and Follow-up of Patients With Monoclonal Gammopathy of Undetermined Significance

The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists

Relationship between anti-diarrheal activity and binding to calmodulin

Histamine receptors in the myenteric plexus-longitudinal muscle of the guinea-pig ileum: H1- and H2-receptor-mediated potentiation of the contractile response to electrical stimulation

A Facile and Versatile Synthesis of 2-Substituted Tryptophans as Nα-tert- Butyloxycarbonyl Derivatives

Regulation by monovalent cations of histamine H2 receptor-coupled adenylate cyclase from guinea pig fundic gastric mucosa

Imidazole derivatives—A new class of microsomal enzyme inhibitors

Estradiol 17β-hemisuccinate: an improved procedure

Differences in the interaction of histamine H2 receptor antagonists and tricyclic antidepressants with adenylate cyclase from guinea pig gastric mucosa

Suchergebnisse filtern